[FG] Briel Matthias

Stojanov, T. et al. (2025) ‘Baseline characteristics and 2-year functional outcome data of patients undergoing an arthroscopic rotator cuff repair in Switzerland, results of the ARCR_Pred study’, PLOS ONE, 20(1), p. e0316712. Available at: https://doi.org/10.1371/journal.pone.0316712.

Pesonel, E. et al. (2025) ‘Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC)’, Clinical Infectious Diseases [Preprint]. Available at: https://doi.org/10.1093/cid/ciae657.

Hampanda, K. et al. (2024) ‘HIV Risk and Intention to use PrEP among Sexually Active Female University Students in Zambia: A Cross-Sectional Survey to Understand Influential Factors’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.12.12.24318948.

Gsteiger, S. et al. (2024) ‘Technology Assessment vs. Technology Appraisal—How to Strengthen the Science/Value Dichotomy with EU HTA?’, Journal of Market Access & Health Policy, 12(4), pp. 369–377. Available at: https://doi.org/10.3390/jmahp12040028.

Firima, Emmanuel et al. (2024) ‘Prevalence of hepatitis B virus infection and treatment eligibility in Lesotho, Southern Africa: a population-based cross-sectional study with case-based follow-up’, BMJ Public Health, 2(2), p. e001195. Available at: https://doi.org/10.1136/bmjph-2024-001195.

Ehrenzeller, S. et al. (2024) ‘Risk of SARS-CoV-2 infection in hospitalized patients following SARS-CoV-2 exposures before and during hospitalization’, Infection Control & Hospital Epidemiology, pp. 1–4. Available at: https://doi.org/10.1017/ice.2024.136.

Gerber, F. et al. (2024) ‘Cohort profile: design, sociodemographic characteristics, chronic disease risk factors, and baseline hypertension and diabetes care cascades of the open, prospective Community-Based chronic disease Care Lesotho (ComBaCaL) cohort’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2024.09.18.24313892.

Erhart, C.-C. et al. (2024) ‘Prognostic value of KRAS G12C in advanced non-small cell lung cancer with high PD-L1 expression treated with upfront immunotherapy: a systematic review and meta-analysis’, Swiss Medical Weekly, 154(7), p. 3695. Available at: https://doi.org/10.57187/s.3695.

Manyara, Anthony Muchai et al. (2024) ‘Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration’, BMJ, 386, p. 18. Available at: https://doi.org/10.1136/bmj-2023-078524.

Julian, E. et al. (2024) ‘The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy’, Journal of Market Access & Health Policy, 12(3), pp. 128–143. Available at: https://doi.org/10.3390/jmahp12030011.

Wang, Ying et al. (2024) ‘Proton-Pump Inhibitors to Prevent Gastrointestinal Bleeding — An Updated Meta-Analysis’, NEJM Evidence [Preprint]. Available at: https://doi.org/10.1056/evidoa2400134.

Ehrenzeller, S. et al. (2024) ‘Cycle threshold dynamics of non-severe acute respiratory coronavirus virus 2 (SARS-CoV-2) respiratory viruses’, Infection Control and Hospital Epidemiology, 45(5), pp. 630–634. Available at: https://doi.org/10.1017/ice.2023.286.

Gerber, F. et al. (2024) Community-based management of arterial hypertension and cardiovascular risk factors by lay village health workers for people with controlled and uncontrolled blood pressure in rural Lesotho: Joint protocol for two cluster-randomized trials within the ComBaCaL cohort study (ComBaCaL aHT Twic 1 & ComBaCaL aHT TwiC 2). Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-3805346/v1.

Haug, N. et al. (2024) ‘Quantifying bias due to missing data in quality of life surveys of advanced-stage cancer patients’, Quality of Life Research, 33(4), pp. 1085–1094. Available at: https://doi.org/10.1007/s11136-023-03588-7.

Brune, D. et al. (2024) ‘Factors Associated With Preoperative Quality of Life in Patients With Rotator Cuff Injury’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-3982051/v1.

Ehrenzeller, S. and Klompas, M. (2024) ‘Association Between Daily Toothbrushing and Hospital-Acquired Pneumonia A Systematic Review and Meta-Analysis’, JAMA Internal Medicine, 184(2), pp. 131–142. Available at: https://doi.org/10.1001/jamainternmed.2023.6638.

Baum, Cornelia et al. (2024) ‘Functional and Radiologic Outcomes of Degenerative Versus Traumatic Full-Thickness Rotator Cuff Tears Involving the Supraspinatus Tendon’, The American Journal of Sports Medicine, 52(2), pp. 441–450. Available at: https://doi.org/10.1177/03635465231219253.

Amstutz, A. et al. (2024) ‘Effects of Jak Inhibitors in Adults Hospitalized Due to Covid-19: A Systematic Review and Individual Participant Data Meta-Analysis of Randomized Clinical Trials’. Elsevier BV. Available at: https://doi.org/10.2139/ssrn.4974193.

Amstutz, Alain et al. (2024) ‘Characteristics, consent patterns, and challenges of randomized trials using the Trials within Cohorts (TwiCs) design - A scoping review’, Journal of Clinical Epidemiology, 174. Available at: https://doi.org/10.1016/j.jclinepi.2024.111469.

Belus, Jennifer M. et al. (2024) ‘SMSs as an alternative to provider-delivered care for unhealthy alcohol use: study protocol for Leseli, an open-label randomised controlled trial of mhGAP-Remote vs mhGAP-Standard in Lesotho’, Trials, 25. Available at: https://doi.org/10.1186/s13063-024-08411-3.

Chammartin, Frédérique et al. (2024) ‘Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1’, AIDS, 38, pp. 217–222. Available at: https://doi.org/10.1097/qad.0000000000003751.

Fernández, Lucia González et al. (2024) ‘Awareness, treatment, and control among adults living with arterial hypertension or diabetes mellitus in two rural districts in Lesotho’, PLOS Global Public Health, 4(9). Available at: https://doi.org/10.1371/journal.pgph.0003721.

Fernández, Lucia González et al. (2024) ‘Prevalence of Mental Health and Substance use Problems and Awareness of Need for Services in Lesotho: Results from a Population-Based Survey’, International Journal of Mental Health and Addiction [Preprint]. Available at: https://doi.org/10.1007/s11469-024-01309-w.

Firima, E. et al. (2024) ‘Implementing focused echocardiography and AI-supported analysis in a population-based survey in Lesotho: implications for community-based cardiovascular disease care models’, Hypertension Research, 47, pp. 708–713. Available at: https://doi.org/10.1038/s41440-023-01559-6.

Gerber, Felix et al. (2024) ‘Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: Protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi’, PLoS ONE, 19. Available at: https://doi.org/10.1371/journal.pone.0288944.

Gerber, Felix et al. (2024) ‘eConsent administered by Community Health Workers in a study using the Trials within Cohorts (TwiCs) design—Experiences from the Community-Based chronic Care Lesotho (ComBaCaL) project’, Digital Health, 10. Available at: https://doi.org/10.1177/20552076241288757.

Griessbach, Alexandra et al. (2024) ‘Characteristics, Progression, and Output of Randomized Platform Trials: A Systematic Review’, in A Systematic Review. (A Systematic Review), p. E243109. Available at: https://doi.org/10.1001/jamanetworkopen.2024.3109.

Griessbach, Alexandra et al. (2024) ‘Resource use and costs of investigator-sponsored randomized clinical trials in Switzerland, Germany, and the United Kingdom: a metaresearch study’, Journal of Clinical Epidemiology, 176. Available at: https://doi.org/10.1016/j.jclinepi.2024.111536.

Hirt, Julian et al. (2024) ‘Searching a methods topic: practical challenges and implications for search design’, Journal of Clinical Epidemiology. 30.10.2023, 166. Available at: https://doi.org/10.1016/j.jclinepi.2023.10.017.

Jackson-Perry, David et al. (2024) ‘Patient and public involvement in HIV research: a mapping review and development of an online evidence map’, Journal of the International AIDS Society, 27. Available at: https://doi.org/10.1002/jia2.26385.

Manyara, Anthony Muchai et al. (2024) ‘Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration’, BMJ, 386, p. 19. Available at: https://doi.org/10.1136/bmj-2023-078525.

Raeber, Fabian et al. (2024) ‘Community-based models of care for adolescent and adult depression, suicidal behavior, anxiety, trauma, and substance use in Africa: a scoping review’, Frontiers in Psychology, 15. Available at: https://doi.org/10.3389/fpsyg.2024.1241403.

Schandelmaier, Stefan and Guyatt, Gordon (2024) ‘Same Old Challenges in Subgroup Analysis - Should We Do More About Methods Implementation?’, JAMA Network Open, 7, p. E243339. Available at: https://doi.org/10.1001/jamanetworkopen.2024.3339.

Schorb, Elisabeth et al. (2024) ‘High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial’, The Lancet Haematology, null. Available at: https://doi.org/10.1016/s2352-3026(23)00371-x.

Wang, Y. et al. (2024) ‘Compelling evidence from meta-epidemiological studies demonstrates overestimation of effects in randomized trials that fail to optimize randomization and blind patients and outcome assessors’, Journal of Clinical Epidemiology, 165. Available at: https://doi.org/10.1016/j.jclinepi.2023.11.001.

Klatte, K. et al. (2023) ‘Towards full clinical trial registration and results publication: longitudinal meta-research study in Northwestern and Central Switzerland’, BMC Medical Research Methodology, 23(1). Available at: https://doi.org/10.1186/s12874-023-01840-9.

Troseid M. et al. (2023) ‘Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial’, Critical Care, 27(1). Available at: https://doi.org/10.1186/s13054-022-04205-8.

Griessbach, Alexandra et al. (2023) ‘Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)’, Open Forum Infectious Diseases, 10(11). Available at: https://doi.org/10.1093/ofid/ofad536.

Gerber, F. et al. (2023) Community-based type 2 diabetes care by lay village health workers in rural Lesotho Protocol for a cluster-randomized trial within the ComBaCaL cohort study (ComBaCaL T2D TwiC). Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-3252316/v1.

Simwinga, M. et al. (2023) ‘Facilitators and barriers to COVID-19 testing in community and clinical settings: Lessons learned from Lesotho and Zambia’, PLOS Global Public Health, 3(10), p. e0002430. Available at: https://doi.org/10.1371/journal.pgph.0002430.

Firima, Emmanuel et al. (2023) ‘Head-to-head comparison of the WHO STEPwise approach with immediate unattended and delayed unattended automated blood pressure measurements during household-based screening: a diagnostic accuracy study in Lesotho’, eClinicalMedicine, 63, p. 102197. Available at: https://doi.org/10.1016/j.eclinm.2023.102197.

González Fernández L et al. (2023) ‘Prevalence and determinants of cardiovascular risk factors in Lesotho: a population-based survey.’, International health [Preprint]. Available at: https://doi.org/10.1093/inthealth/ihad058.

González Fernández, Lucia et al. (2023) ‘Prevalence and determinants of cardiovascular risk factors in Lesotho: a population-based survey’, International Health [Preprint]. Available at: https://doi.org/10.1093/inthealth/ihad058.

Fernández, Lucia González et al. (2023) ‘Awareness, treatment, and control among adults living with arterial hypertension or diabetes mellitus in two rural districts in Lesotho’. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-3189573/v1.

Yao, M. et al. (2023) ‘Evaluating the impact of including non-randomised studies of interventions in meta-analysis of randomised controlled trials: A protocol for a meta-epidemiological study’, BMJ Open, 13(7). Available at: https://doi.org/10.1136/bmjopen-2023-073232.

Gerber, F. et al. (2023) Same-day versus rapid ART initiation in HIV-positive individuals presenting with symptoms of tuberculosis: protocol for an open-label randomized non-inferiority trial in Lesotho and Malawi. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2023.07.10.23292457.

Schlussel MM et al. (2023) ‘Reporting guidelines used varying methodology to develop recommendations.’, Journal of clinical epidemiology, 159, pp. 246–256. Available at: https://doi.org/10.1016/j.jclinepi.2023.03.018.

Dhiman P et al. (2023) ‘Overinterpretation of findings in machine learning prediction model studies in oncology: a systematic review.’, Journal of clinical epidemiology, 157, pp. 120–133. Available at: https://doi.org/10.1016/j.jclinepi.2023.03.012.

Hayoz S et al. (2023) ‘Completion and publication of clinical trials in a cooperative group: a cohort study of trials of the Swiss Group for Clinical Cancer Research (SAKK).’, BMJ open, 13(4), p. e068490. Available at: https://doi.org/10.1136/bmjopen-2022-068490.

Hoang-Xuan K et al. (2023) ‘European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL).’, Neuro-oncology, 25(1), pp. 37–53. Available at: https://doi.org/10.1093/neuonc/noac196.

Amstutz, Alain et al. (2023) ‘Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials’, The Lancet Respiratory Medicine, 11(5), pp. 453–464. Available at: https://doi.org/10.1016/s2213-2600(22)00528-8.

Ciani, O. et al. (2023) ‘A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials’, eClinicalMedicine, 65. Available at: https://doi.org/10.1016/j.eclinm.2023.102283.

Ebrahimi, Fahim et al. (2023) ‘Colchicine for the secondary prevention of cardiovascular events’, Cochrane Database of Systematic Reviews. 29.08.2023, 2023(8). Available at: https://doi.org/10.1002/14651858.cd014808.

Finazzi, Tobias et al. (2023) ‘Patient Reported Outcome Measures (PROMs) in a multidisciplinary lung cancer centre: a value-based healthcare pilot project’, SOCH. Schweiz (SOCH), 1 January. Available at: https://www.researchgate.net/publication/378675035_Patient_Reported_Outcome_Measures_PROMs_in_a_multidisciplinary_lung_cancer_centre_a_value-based_healthcare_pilot_project.

Firima, Emmanuel et al. (2023) ‘High Rates of Undiagnosed Target Organ Damage Among Adults with Elevated Blood Pressure or Diabetes Mellitus in a Community-Based Survey in Lesotho’, Journal of Epidemiology and Global Health, 13, pp. 857–869. Available at: https://doi.org/10.1007/s44197-023-00158-5.

Firima, Emmanuel et al. (2023) ‘Community-based models of care for management of type 2 diabetes mellitus among non-pregnant adults in sub-Saharan Africa: A scoping review’, PLoS ONE, 18. Available at: https://doi.org/10.1371/journal.pone.0278353.

Garweg, Justus G. et al. (2023) ‘Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects’, Ophthalmology and Therapy, 12, pp. 639–655. Available at: https://doi.org/10.1007/s40123-023-00647-7.

Gloy, Viktoria et al. (2023) ‘The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020’, International Journal of Cancer, 152, pp. 2474–2484. Available at: https://doi.org/10.1002/ijc.34473.

Griessbach, Alexandra et al. (2023) ‘Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)’, Open Forum Infectious Diseases, 10. Available at: https://doi.org/10.1093/ofid/ofad150.

Griessbach, Alexandra et al. (2023) ‘Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)’, Open Forum Infectious Diseases, 10. Available at: https://doi.org/10.1093/ofid/ofad536.

Guyatt, Gordon et al. (2023) ‘GRADE guidance 36: updates to GRADE’s approach to addressing inconsistency’, Journal of Clinical Epidemiology, 158, pp. 70–83. Available at: https://doi.org/10.1016/j.jclinepi.2023.03.003.

Hirt, J. et al. (2023) ‘Introducing the Library of Guidance for Health Scientists (LIGHTS): a living database for methods guidance’, JAMA Netw Open, 6(2), p. e2253198. Available at: https://doi.org/10.1001/jamanetworkopen.2022.53198.

Hirt, Julian et al. (2023) ‘Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: A systematic review’, Archives of Disease in Childhood, 108, pp. 498–505. Available at: https://doi.org/10.1136/archdischild-2022-324455.

Katende, B. et al. (2023) ‘Impact of a multi-disease integrated screening and diagnostic model for COVID-19, TB, and HIV in Lesotho’, PLOS Glob Public Health, 3(8), p. e0001488. Available at: https://doi.org/10.1371/journal.pgph.0001488.

Komminoth, Mathis et al. (2023) ‘Glucocorticoid withdrawal and glucocorticoidinduced adrenal insufficiency: Study protocol of the randomized controlled «TOASST’ (Taper Or Abrupt Steroid STop) multicenter trial’, PLoS ONE, 18. Available at: https://doi.org/10.1371/journal.pone.0281585.

Kopo, M. et al. (2023) ‘Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: the PEBRA cluster-randomized trial’, PLoS Med, 20(1), p. e1004150. Available at: https://doi.org/10.1371/journal.pmed.1004150.

Lengsfeld, Sophia et al. (2023) ‘Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)—a structured summary of a study protocol for a randomized controlled study’, Trials, 24. Available at: https://doi.org/10.1186/s13063-023-07164-9.

Lengsfeld, Sophia et al. (2023) ‘Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial’, eClinicalMedicine, 57. Available at: https://doi.org/10.1016/j.eclinm.2023.101865.

Martens, U.M. et al. (2023) ‘The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice’, BMC Cancer, 23. Available at: https://doi.org/10.1186/s12885-023-11046-3.

McLennan, S. and Briel, M. (2023) ‘A call for error management in academic clinical research’, Journal of Clinical Epidemiology, 154, pp. 208–211. Available at: https://doi.org/10.1016/j.jclinepi.2022.11.023.

Speich, Benjamin et al. (2023) ‘Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials’, JAMA Network Open, 6. Available at: https://doi.org/10.1001/jamanetworkopen.2023.17651.

Speich, Benjamin, Schroter, Sara and Briel, Matthias (2023) ‘Guidance needed: where should randomized studies which do not assess a health outcome be registered?’, Journal of Clinical Epidemiology, 161, pp. 183–184. Available at: https://doi.org/10.1016/j.jclinepi.2023.07.016.

Amstutz, Alain et al. (2023) ‘Effects of Remdesivir in Hospitalized Patients with COVID-19: Systematic Review and Individual Patient Data Meta-Analysis of Randomized Clinical Trials’, LANCET RESPIRATORY MEDICINE [Preprint].

Gordon Guyatt et al. (2023) ‘GRADE Guidance 36: Updates to GRADE’s approach to addressing inconsistency’, Journal of Clinical Epidemiology [Preprint].

Julian Hirt et al. (2023) ‘Introducing the Library of Guidance for Health Scientists (LIGHTS): a living database for methods guidance’, JAMA Network Open. Fab 14, 2023, 2(6), p. e2253198.

Bresser, M. et al. (2022) Evaluation of Covid-19 Ag-RDTs self-testing in Lesotho and Zambia. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.12.21.22283827.

Katende, B. et al. (2022) Impact of a multi-disease integrated screening and diagnostic model for COVID-19, TB, and HIV in Lesotho. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.12.20.22283748.

Hirt, Julian et al. (2022) ‘Library of Guidance for Health Scientists (LIGHTS): Eine neue Datenbank für methodische Leitlinien in der klinischen Forschung’, GMS Medizin - Bibliothek - Information. 20.12.2022, 22(2). Available at: https://doi.org/10.3205/mbi000546.

Gloy, Viktoria et al. (2022) ‘Scoping review and characteristics of publicly available checklists for assessing clinical trial feasibility’, BMC Medical Research Methodology, 22(1). Available at: https://doi.org/10.1186/s12874-022-01617-6.

Wang, Y. et al. (2022) ‘Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issues’, Journal of Clinical Epidemiology, 152, pp. 218–225. Available at: https://doi.org/10.1016/j.jclinepi.2022.10.018.

Klatte, K. et al. (2022) Development of a Risk-tailored Approach and Dashboard for Efficient Management and Monitoring of Investigator-Initiated Trials. Research Square Platform LLC. Available at: https://doi.org/10.21203/rs.3.rs-2051504/v1.

Stanczak MA et al. (2022) ‘Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade.’, Science translational medicine, 14(669), p. eabj1270. Available at: https://doi.org/10.1126/scitranslmed.abj1270.

Carrasco-Labra A et al. (2022) ‘Serious reporting deficiencies exist in minimal important difference studies: current state and suggestions for improvement.’, Journal of clinical epidemiology, 150, pp. 25–32. Available at: https://doi.org/10.1016/j.jclinepi.2022.06.010.

Nørgaard B et al. (2022) ‘A systematic review of meta-research studies finds substantial methodological heterogeneity in citation analyses to monitor evidence-based research.’, Journal of clinical epidemiology, 150, pp. 126–141. Available at: https://doi.org/10.1016/j.jclinepi.2022.06.021.

Hirt J et al. (2022) ‘A systematic survey of methods guidance suggests areas for improvement regarding access, development, and transparency.’, Journal of clinical epidemiology, 149, pp. 217–226. Available at: https://doi.org/10.1016/j.jclinepi.2022.05.005.

Schönenberger, Christof Manuel et al. (2022) ‘A meta-research study of randomized controlled trials found infrequent and delayed availability of protocols’, Journal of Clinical Epidemiology, 149, pp. 45–52. Available at: https://doi.org/10.1016/j.jclinepi.2022.05.014.

Schönenberger CM et al. (2022) ‘A meta-research study of randomized controlled trials found infrequent and delayed availability of protocols.’, Journal of clinical epidemiology, 149, pp. 45–52. Available at: https://doi.org/10.1016/j.jclinepi.2022.05.014.

Chammartin F et al. (2022) ‘Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV.’, AIDS (London, England), 36(10), pp. 1465–1468. Available at: https://doi.org/10.1097/qad.0000000000003246.

Speich B et al. (2022) ‘A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study.’, Trials, 23(1), p. 601. Available at: https://doi.org/10.1186/s13063-022-06516-1.

Dhiman P et al. (2022) ‘Risk of bias of prognostic models developed using machine learning: a systematic review in oncology.’, Diagnostic and prognostic research, 6(1), p. 13. Available at: https://doi.org/10.1186/s41512-022-00126-w.

Schmitt AM et al. (2022) ‘Characteristics and survival of patients with cancer with intended off-label use-a cohort study.’, BMJ open, 12(5), p. e060453. Available at: https://doi.org/10.1136/bmjopen-2021-060453.

Speich, Benjamin et al. (2022) ‘Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis’, PLOS Medicine, 19(4), p. e1003980. Available at: https://doi.org/10.1371/journal.pmed.1003980.

Dhiman P et al. (2022) ‘Methodological conduct of prognostic prediction models developed using machine learning in oncology: a systematic review.’, BMC medical research methodology, 22(1), p. 101. Available at: https://doi.org/10.1186/s12874-022-01577-x.

Borisov AN et al. (2022) ‘No obesity paradox in patients with community-acquired pneumonia - secondary analysis of a randomized controlled trial.’, Nutrition & diabetes, 12(1), p. 12. Available at: https://doi.org/10.1038/s41387-022-00190-7.

Hirt, J. et al. (2022) ‘Validity of reported post-acute health outcomes in children with SARS-CoV-2 infection: a systematic review’. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.03.18.22272582.

Blum CA et al. (2022) ‘Relevance of cortisol and copeptin blood concentration changes in an experimental pain model.’, Scientific reports, 12(1), p. 4767. Available at: https://doi.org/10.1038/s41598-022-08657-4.

Merkofer F et al. (2022) ‘Glucose control after glucocorticoid administration in hospitalized patients - a retrospective analysis.’, BMC endocrine disorders, 22(1), p. 8. Available at: https://doi.org/10.1186/s12902-021-00914-3.

Trøseid, M. et al. (2022) ‘Efficacy and Safety of Baricitinib for the Treatment of Hospitalized Adults with Severe or Critical COVID-19 (Bari-SolidAct): A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Trial’, SSRN Electronic Journal [Preprint]. Available at: https://doi.org/10.2139/ssrn.4172086.

Briel, Matthias et al. (2022) ‘Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada’, Trials, 22(1), p. 844. Available at: https://doi.org/10.1186/s13063-021-05818-0.

Brown, J. A. et al. (2022) ‘Dolutegravir in real life: self-reported mental and physical health outcomes after transitioning from efavirenz- to dolutegravir-based antiretroviral therapy in a prospective cohort study in Lesotho’, HIV Med, 24(2), pp. 153–162. Available at: https://doi.org/10.1111/hiv.13352.